Humanigen Inc (HGENQ)
0.00
USD |
OTCM |
Jul 01, 16:00
Humanigen Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.02M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -0.03M |
| September 30, 2018 | 0.03M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | |
| December 31, 2016 | 0.011M |
| September 30, 2016 | -0.042M |
| Date | Value |
|---|---|
| June 30, 2016 | -0.009M |
| March 31, 2016 | 0.143M |
| December 31, 2015 | 0.557M |
| September 30, 2015 | 6.897M |
| June 30, 2015 | 10.63M |
| March 31, 2015 | 12.01M |
| December 31, 2014 | 7.797M |
| September 30, 2014 | 11.90M |
| June 30, 2014 | -19.15M |
| March 31, 2014 | -8.773M |
| December 31, 2013 | 9.045M |
| September 30, 2013 | 12.08M |
| June 30, 2013 | -37.44M |
| March 31, 2013 | 2.39M |
| December 31, 2012 | 8.877M |
| September 30, 2012 | -0.789M |
| June 30, 2012 | -7.698M |
| March 31, 2012 | 4.685M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.02M
Minimum
Sep 2020
--
Maximum
Sep 2019
-0.005M
Average
--
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Cannabis Global Inc | 0.0437M |
| Cantabio Pharmaceuticals Inc | -- |
| Calithera Biosciences Inc | -0.023M |
| Predictive Technology Group Inc | 0.3224M |
| Statera BioPharma Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.059M |
| Free Cash Flow | -64.32M |
| Free Cash Flow Per Share (Quarterly) | -0.0593 |
| Free Cash Flow to Equity (Quarterly) | -7.059M |